Philips Introduces First at-Home, 12-lead ECG Integrated Solution for Decentralized Clinical Trials
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry's first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company's cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services. 
One year after implementing TeleTracking's patient flow platform, Maidstone and Tunbridge Wells NHS Trust (MTW) has significantly improved capacity management and operational efficiencies across the 512-bed organisation. As part of the Trust's digital strategy, TeleTracking's software centralises capacity management and creates shared visibility and automation around staff workflows. Now a year into their digital journey, 
A leading global healthcare system, Cleveland Clinic, has launched a landmark study to better understand why millions of people around the world suffer from brain diseases, with the goal of pinpointing disease biomarkers early, well before clinical symptoms present themselves. 
Huma has bought iPLATO Healthcare, whose patient engagement software covers a network of 26.6m patients across nearly 3,000 NHS primary care organisations and whose myGP app is one of the most downloaded medical apps in the UK. The two companies will continue to operate independently but will combine their expertise to enable more proactive, predictive and personalised care for patients in a joined-up service across primary and secondary care.